Cargando…
Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
Autor principal: | Schramm, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947690/ https://www.ncbi.nlm.nih.gov/pubmed/35328161 http://dx.doi.org/10.3390/diagnostics12030608 |
Ejemplares similares
-
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
por: Li, Xiaoqing, et al.
Publicado: (2022) -
BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study
por: Li, Xiaoqing, et al.
Publicado: (2021) -
COLLABORATION AGREEMENT No. KE2364/TE
por: The European Organization for Nuclear Research, CERN, et al.
Publicado: (2014) -
BDP1 as a biomarker in serous ovarian cancer
por: Cabarcas‐Petroski, Stephanie, et al.
Publicado: (2022) -
Comment on Pashchanka, M. Conceptual Progress for Explaining and Predicting Self-Organization on Anodized Aluminum Surfaces. Nanomaterials 2021, 11, 2271
por: Heinschke, Silvio, et al.
Publicado: (2023)